DK0722492T3 - Stabilisering af proteiner i oplösning - Google Patents

Stabilisering af proteiner i oplösning

Info

Publication number
DK0722492T3
DK0722492T3 DK94928946T DK94928946T DK0722492T3 DK 0722492 T3 DK0722492 T3 DK 0722492T3 DK 94928946 T DK94928946 T DK 94928946T DK 94928946 T DK94928946 T DK 94928946T DK 0722492 T3 DK0722492 T3 DK 0722492T3
Authority
DK
Denmark
Prior art keywords
alkyl
pct
sec
hydroxyalkyl
sulphonate
Prior art date
Application number
DK94928946T
Other languages
Danish (da)
English (en)
Inventor
Timothy David Gibson
Barry Leigh John Pierce
Jeanette Irene Webster
Original Assignee
Univ Leeds Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leeds Innovations Ltd filed Critical Univ Leeds Innovations Ltd
Application granted granted Critical
Publication of DK0722492T3 publication Critical patent/DK0722492T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK94928946T 1993-10-08 1994-10-06 Stabilisering af proteiner i oplösning DK0722492T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939320782A GB9320782D0 (en) 1993-10-08 1993-10-08 Stabilising of proteins on solution
PCT/GB1994/002180 WO1995010605A1 (en) 1993-10-08 1994-10-06 Stabilisation of proteins in solution

Publications (1)

Publication Number Publication Date
DK0722492T3 true DK0722492T3 (da) 2005-07-11

Family

ID=10743227

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94928946T DK0722492T3 (da) 1993-10-08 1994-10-06 Stabilisering af proteiner i oplösning

Country Status (8)

Country Link
US (1) US6133229A (de)
EP (1) EP0722492B1 (de)
AT (1) ATE290590T1 (de)
AU (1) AU7817094A (de)
DE (1) DE69434290T2 (de)
DK (1) DK0722492T3 (de)
GB (1) GB9320782D0 (de)
WO (1) WO1995010605A1 (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6689265B2 (en) 1995-10-11 2004-02-10 Therasense, Inc. Electrochemical analyte sensors using thermostable soybean peroxidase
GB9708641D0 (en) 1997-04-29 1997-06-18 Knoll Ag Enzyme concentrate
JP4841726B2 (ja) 1999-02-05 2011-12-21 メルク・シャープ・エンド・ドーム・コーポレイション ヒトパピローマウイルスワクチン製剤
AU2001220765A1 (en) 2000-01-24 2001-07-31 Medtronic Minimed, Inc. Mixed buffer system for stabilizing polypeptide formulations
CA2430127C (en) 2000-11-29 2010-04-20 Novartis Ag Aqueous disinfecting system comprising a microbicide and 1,3-bis(tris[hydroxymethyl]methylamino)propane
JP2004525369A (ja) * 2001-03-07 2004-08-19 インスツルメンテーション ラボラトリー カンパニー 参照電極
EP1252879A1 (de) * 2001-04-27 2002-10-30 Cosmoferm B.V. Stabilisierte Enzym Zusammensetzungen
US6652720B1 (en) 2001-05-31 2003-11-25 Instrumentation Laboratory Company Analytical instruments, biosensors and methods thereof
US6872297B2 (en) * 2001-05-31 2005-03-29 Instrumentation Laboratory Company Analytical instruments, biosensors and methods thereof
US6960466B2 (en) * 2001-05-31 2005-11-01 Instrumentation Laboratory Company Composite membrane containing a cross-linked enzyme matrix for a biosensor
ES2298378T3 (es) 2001-06-28 2008-05-16 Novo Nordisk A/S Formulacion estable de glp-1 modificado.
US6737401B2 (en) * 2001-06-28 2004-05-18 Metronic Minimed, Inc. Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
US7422903B2 (en) * 2002-12-11 2008-09-09 Instrumentation Laboratory Company Multi-analyte reference solutions
US20040256227A1 (en) * 2003-02-11 2004-12-23 Jungwon Shin Electrochemical urea sensors and methods of making the same
US20040154933A1 (en) * 2003-02-11 2004-08-12 Instrumentation Laboratory Company Polymeric membranes for use in electrochemical sensors
CN102940879B (zh) * 2003-06-03 2017-06-06 诺沃挪第克公司 稳定化的药物肽组合物
WO2004105790A1 (en) 2003-06-03 2004-12-09 Novo Nordisk A/S Stabilized pharmaceutical peptide compositions
WO2005049061A2 (en) 2003-11-20 2005-06-02 Novo Nordisk A/S Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
SG151298A1 (en) 2004-04-08 2009-04-30 Biomatrica Inc Integration of sample storage and sample management for life science
US7740861B2 (en) * 2004-06-16 2010-06-22 University Of Massachusetts Drug delivery product and methods
ES2442223T3 (es) 2004-08-31 2014-02-10 Novo Nordisk A/S Uso de tris(hidroximetil) aminometano para la estabilización de péptidos, polipéptidos y proteínas
CA2580537C (en) 2004-09-17 2015-04-21 University Of Massachusetts Compositions and their uses for lysosomal enzyme deficiencies
BRPI0517341A (pt) 2004-11-12 2008-10-07 Novo Nordisk As composição farmacêutica estável em prateleira, métodos para a preparação de uma composição farmacêutica, para o tratamento de hiperglicemia, para o tratamento de obesidade, deficiência de célula beta, igt ou dislipidemia, para a preparação de uma solução estável de um composto glp-1, para a preparação de um composto glp-1 estável e para a preparação de uma composição farmacêutica estável em prateleira de um composto glp-1, solução estável de um composto glp-1, e, uso de uma solução estável de um composto glp-1
AU2006247188A1 (en) 2005-05-18 2006-11-23 Children's Hospital & Research Center At Oakland Methods and compositions for immunizing against chlamydia infection
US20070031914A1 (en) * 2005-08-05 2007-02-08 Wei Zhu Devices for analyte assays and methods of use
WO2009026122A1 (en) * 2007-08-17 2009-02-26 Amgen Inc. Formulations of antibodies and fc-fusion molecules using polycations
CA2704056A1 (en) * 2007-10-29 2009-05-07 University Of Massachusetts Encapsulated nanoparticles for nucleic acid delivery
WO2010008582A2 (en) 2008-07-18 2010-01-21 Rxi Pharmaceuticals Corporation Phagocytic cell drug delivery system
CA2746527A1 (en) 2008-09-22 2010-03-25 Rxi Pharmaceuticals Corporation Rna interference in skin indications
US9493774B2 (en) 2009-01-05 2016-11-15 Rxi Pharmaceuticals Corporation Inhibition of PCSK9 through RNAi
WO2010090762A1 (en) 2009-02-04 2010-08-12 Rxi Pharmaceuticals Corporation Rna duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
EP2552478B1 (de) 2010-03-31 2016-12-21 Stabilitech Ltd. Hilfsstoffe zur stabilisierung von viralen partikeln
US10206960B2 (en) 2010-03-31 2019-02-19 Stabilitech Biopharma Ltd Stabilisation of viral particles
US9376709B2 (en) 2010-07-26 2016-06-28 Biomatrica, Inc. Compositions for stabilizing DNA and RNA in blood and other biological samples during shipping and storage at ambient temperatures
EP2598661B1 (de) 2010-07-26 2017-09-27 Biomatrica, INC. Zusammensetzungen zur stabilisierung von dna, rna und proteinen in speichel- und anderen biologischen proben während des transports und der lagerung bei umgebungstemperaturen
EP2603450B1 (de) 2010-08-14 2016-11-02 University of Massachusetts Wandpartikel aus hefezellen für rezeptorengerichtete nanopartikelfreisetzung
US11246915B2 (en) 2010-09-15 2022-02-15 Applied Molecular Transport Inc. Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
NO2616045T3 (de) 2010-09-15 2018-03-24
GB201117233D0 (en) * 2011-10-05 2011-11-16 Stabilitech Ltd Stabilisation of polypeptides
EP3249054A1 (de) 2012-12-20 2017-11-29 Biomatrica, INC. Formulierungen und verfahren zur stabilisierung von pcr-reagenzien
GB201406569D0 (en) 2014-04-11 2014-05-28 Stabilitech Ltd Vaccine compositions
IL285716B (en) 2014-05-07 2022-09-01 Applied Molecular Transp Llc Compacted molecules derived from colic toxin for oral delivery of biologically active cargo
JP6661554B2 (ja) 2014-06-10 2020-03-11 バイオマトリカ，インク． 周囲温度における血小板の安定化
JP2018521129A (ja) * 2015-07-07 2018-08-02 ナノビオ コーポレイションＮａｎｏｂｉｏ Ｃｏｒｐｏｒａｔｉｏｎ タンパク質の安定化のための方法および組成物
US11173197B2 (en) 2015-07-07 2021-11-16 Bluewillow Biologics, Inc. Methods and compositions for nanoemulsion vaccine formulations
WO2017100212A1 (en) 2015-12-08 2017-06-15 Biomatrica, Inc. Reduction of erythrocyte sedimentation rate
GB2562241B (en) 2017-05-08 2022-04-06 Stabilitech Biopharma Ltd Vaccine compositions
MX2020001525A (es) 2017-08-24 2020-03-20 Novo Nordisk As Composiciones de peptido similar al glucagon tipo 1 (glp-1) y sus usos.
CA3093386A1 (en) 2018-03-08 2019-09-12 Applied Molecular Transport Inc. Toxin-derived delivery constructs for oral delivery
HUE059330T2 (hu) 2018-03-08 2022-11-28 Applied Molecular Transport Inc Toxinból származó bejuttatási konstrukciók orális beadásra
AU2020331939A1 (en) 2019-08-16 2022-03-24 Applied Molecular Transport Inc. Compositions, formulations, and interleukin production and purification
GB202001501D0 (en) 2020-02-04 2020-03-18 Fabricnano Ltd Nucleic acid nanostructures
US20230093542A1 (en) 2020-02-18 2023-03-23 Novo Nordisk A/S Glp-1 compositions and uses thereof
GB202007428D0 (en) 2020-05-19 2020-07-01 Fabricnano Ltd Polynucleotide synthesis
GB202110595D0 (en) 2021-07-22 2021-09-08 Fabricnano Ltd Functionalised nucleic acid structure
CN115494232B (zh) * 2022-10-31 2023-10-27 江苏三联生物工程股份有限公司 4,4-二甲基噁唑啉在制备含辣根过氧化物酶的试剂中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282316A (en) * 1979-09-11 1981-08-04 Modrovich Ivan Endre Stabilized enzymic solutions for determining urea
US4318818A (en) * 1979-11-09 1982-03-09 The Procter & Gamble Company Stabilized aqueous enzyme composition
GB2064543A (en) * 1979-12-07 1981-06-17 Slovenska Akademia Vied An Agent for the Release of Cells From Tissues or From the Surface of a Cultivation Vessel
JPS61176532A (ja) * 1985-01-30 1986-08-08 Green Cross Corp:The プラスミノ−ゲンアクチベ−タ−前駆体の安定化方法
GB8826429D0 (en) * 1988-11-11 1988-12-14 Univ Leeds Ind Service Ltd Enzyme stabilisation systems
US5116729A (en) * 1989-03-10 1992-05-26 Miles Inc. Stabilization of oxidase enzyme-based test strips
GB9006642D0 (en) * 1990-03-24 1990-05-23 Gibson Timothy D Enzyme stabilisation
WO1992011844A1 (en) * 1991-01-03 1992-07-23 Alkermes Controlled Therapeutics, Inc. Stabilization of proteins by cationic biopolymers
US5356800A (en) * 1992-11-30 1994-10-18 Buckman Laboratories International, Inc. Stabilized liquid enzymatic compositions

Also Published As

Publication number Publication date
ATE290590T1 (de) 2005-03-15
EP0722492B1 (de) 2005-03-09
WO1995010605A1 (en) 1995-04-20
US6133229A (en) 2000-10-17
DE69434290D1 (de) 2005-04-14
GB9320782D0 (en) 1993-12-01
AU7817094A (en) 1995-05-04
DE69434290T2 (de) 2005-12-29
EP0722492A1 (de) 1996-07-24

Similar Documents

Publication Publication Date Title
DK0722492T3 (da) Stabilisering af proteiner i oplösning
DK0703911T3 (da) Sekundære aminer som antidiabetiske og antiobesitetsmidler
MY104597A (en) Herbicidal agents.
ES8407029A1 (es) Procedimiento para la produccion de n-aril-sulfonil-n'-pirimidil-ureas.
FI955166A0 (fi) Risperidonipamoaatti
DE59508773D1 (de) Dihydrobenzofurane
NZ216145A (en) Piperidine derivatives and pharmaceutical compositions
DK0680257T3 (da) Stabile, væskeformige sammensætninger og deres anvendelse
DK0528922T3 (da) Hidtil ukendte sulfonylforbindelser
DK0782567T3 (da) Isothiourinstofderivater og fremgangsmåder til deres fremstilling
AU1395283A (en) 1-carboxyalkanoylindoline-2-carboxylic acid esters
NO911113D0 (no) Herbicid middel.
ATE31921T1 (de) Amidine, verfahren zu ihrer herstellung und deren anwendung in der therapie.
GR3017406T3 (en) 1,3,5-triazine-2,4,6-tris-alkylaminocarboxylic acid aminoesters, biocidal agents containing such esters, and methods of preparing them.
ATE163402T1 (de) Substituierte ortho- ethenylphenylessigsäurederivate
BR9307288A (pt) Composto processo para a preparação do mesmo composição herbicida e processo de combate de crescimento de vegetais indesejáveis num local
NZ310385A (en) Novel derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
HU900208D0 (en) Fungicid composition comprising sulfurous acrylic acidester-derivatives as active ingredient and process for preparation thereof
PT925781E (pt) Composicao para despigmentacao
PT731801E (pt) Aminoalquilaminopiridinas substituidas
PH31212A (en) 4-Amino-2-(hetero)aryl-butanamides useful as 5-HT1a-antagonists.
DK178384D0 (da) Iminosulfonamider samt deres fremstilling og anvendelse
SE8303499L (sv) Guaniderade aminofosfonsyraforeningar
DE3877361D1 (de) Aminosalze von alkan-1,n-dicarbonsaeure-mono-(2-sulfato-aethyl)amiden.